Discontinued — last reported Q1 '25
Business Segments · Goodwill as a result of acquisitions
Neuroscience — Goodwill as a result of acquisitions
Over 4 years (FY 2021 to FY 2025), Neuroscience — Goodwill as a result of acquisitions shows a downward trend with a -100.0% CAGR.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ2 2019
Last reportedQ1 2025
How to read this metric
An increase indicates recent M&A activity within the neuroscience space, while a decrease or zero balance suggests a focus on organic growth or that no recent acquisitions have been integrated into this specific segment.
Detailed definition
This metric represents the premium paid over the fair value of net identifiable assets during the acquisition of busines...
Peer comparison
Comparable to 'Goodwill' or 'Acquisition-related Intangibles' reported by peer medical device companies that utilize M&A to expand their neuro-technology portfolios.
Metric ID:
mdt_segment_neuroscience_goodwill_as_a_result_of_acquisitionsHistorical Data
17 periods
| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $52.50M | $6.50M | $6.50M | $6.50M | $6.50M | $615.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | -87.6% | +0.0% | +0.0% | +0.0% | >999% | -100.0% | — | — | — | — | — | — | — | — | — | — |
| YoY Change | — | — | — | — | -87.6% | >999% | -100.0% | -100.0% | -100.0% | -100.0% | — | — | — | — | — | — | — |
Range$0.00 – $615.00M
CAGR-100.0%
Avg YoY Growth>999%
Median YoY Growth-100.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Medtronic's neuroscience — goodwill as a result of acquisitions?
- Medtronic (MDT) reported neuroscience — goodwill as a result of acquisitions of $0.00 in Q1 2025.
- What is the long-term trend for Medtronic's neuroscience — goodwill as a result of acquisitions?
- Over 4 years (2021 to 2025), Medtronic's neuroscience — goodwill as a result of acquisitions has grown at a -100.0% compound annual growth rate (CAGR), from $210.00M to $0.00.
- What does neuroscience — goodwill as a result of acquisitions mean?
- The amount of excess purchase price paid for acquired businesses that is allocated to the Neuroscience segment's balance sheet.